2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow DUR-928: new trials by email Literature Review of DUR-928 trials Research Report on DUR-928
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury DUR-928, Placebo - SARS-CoV-2 | Phase 2 | Terminated | Durect | 2 | 2020-09-21 | 2022-08-05 |
| A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) DUR-928 - Primary Sclerosing Cholangitis | Phase 2 | Terminated | Durect | 5 | 2018-01-22 | 2022-10-17 |
Durect (2)
United States (2)
Alastair Smith, MD (1) · Robert Gordon, MD (1)